109 related articles for article (PubMed ID: 20675036)
21. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
22. Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women.
Grosch-Woerner I; Puch K; Maier RF; Niehues T; Notheis G; Patel D; Casteleyn S; Feiterna-Sperling C; Groeger S; Zaknun D;
HIV Med; 2008 Jan; 9(1):6-13. PubMed ID: 18199167
[TBL] [Abstract][Full Text] [Related]
23. Antiretroviral treatment during pregnancy.
Keiser O; Gayet-Ageron A; Rudin C; Brinkhof MW; Gremlich E; Wunder D; Drack G; Hirschel B; de Tejada BM; ;
AIDS; 2008 Nov; 22(17):2323-30. PubMed ID: 18981771
[TBL] [Abstract][Full Text] [Related]
24. Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy.
Haeri S; Shauer M; Dale M; Leslie J; Baker AM; Saddlemire S; Boggess K
Am J Obstet Gynecol; 2009 Sep; 201(3):315.e1-5. PubMed ID: 19733286
[TBL] [Abstract][Full Text] [Related]
25. Postpartum morbidity associated with advanced HIV disease.
Louis J; Buhari MA; Allen D; Gonik B; Jones TB
Infect Dis Obstet Gynecol; 2006; 2006():79512. PubMed ID: 17485809
[TBL] [Abstract][Full Text] [Related]
26. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
[TBL] [Abstract][Full Text] [Related]
27. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
Tai JH; Udoji MA; Barkanic G; Byrne DW; Rebeiro PF; Byram BR; Kheshti A; Carter JD; Graves CR; Raffanti SP; Sterling TR
J Infect Dis; 2007 Oct; 196(7):1044-52. PubMed ID: 17763327
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of HIV-infected pregnant women: prevention of virus transmission and adverse effects in mother and child].
Boer K; Nellen JF; Kreyenbroek ME; Godfried MH
Ned Tijdschr Geneeskd; 2009; 153():B410. PubMed ID: 19785876
[TBL] [Abstract][Full Text] [Related]
29. HAART during pregnancy and during breastfeeding among HIV-infected women in the developing world: has the time come?
Bulterys M; Wilfert CM
AIDS; 2009 Nov; 23(18):2473-7. PubMed ID: 19838097
[No Abstract] [Full Text] [Related]
30. Hospitalizations of pregnant HIV-infected women in the United States in the era of highly active antiretroviral therapy (HAART).
Bansil P; Jamieson DJ; Posner SF; Kourtis AP
J Womens Health (Larchmt); 2007 Mar; 16(2):159-62. PubMed ID: 17388731
[TBL] [Abstract][Full Text] [Related]
31. Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003.
Martí C; Peña JM; Bates I; Madero R; de José I; Pallardo LF; Arribas JR; Gonzalez-Garcia J; Gonzalez A; Vazquez JJ
Acta Obstet Gynecol Scand; 2007; 86(4):409-15. PubMed ID: 17486461
[TBL] [Abstract][Full Text] [Related]
32. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
[TBL] [Abstract][Full Text] [Related]
33. Impact of GB virus type C infection on mother-to-child HIV transmission in the Women and Infants Transmission Study Cohort.
Handelsman E; Cheng I; Thompson B; Hershow R; Mofenson LM; Hollinger FB; Chen KT; Burchett SK; Klinzman D; Stapleton JT;
HIV Med; 2007 Nov; 8(8):561-7. PubMed ID: 17944690
[TBL] [Abstract][Full Text] [Related]
34. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis.
Kourtis AP; Schmid CH; Jamieson DJ; Lau J
AIDS; 2007 Mar; 21(5):607-15. PubMed ID: 17314523
[TBL] [Abstract][Full Text] [Related]
35. Postoperative morbidity associated with cesarean delivery among human immunodeficiency virus-seropositive women.
Rodriguez EJ; Spann C; Jamieson D; Lindsay M
Am J Obstet Gynecol; 2001 May; 184(6):1108-11. PubMed ID: 11349171
[TBL] [Abstract][Full Text] [Related]
36. Obstetric and perinatal outcome in HIV positive women receiving HAART in urban Nigeria.
Olagbuji BN; Ezeanochie MC; Ande AB; Oboro VO
Arch Gynecol Obstet; 2010 Jun; 281(6):991-4. PubMed ID: 19629507
[TBL] [Abstract][Full Text] [Related]
37. Hospitalizations of pregnant HIV-infected women in the USA prior to and during the era of HAART, 1994-2003.
Kourtis AP; Bansil P; McPheeters M; Meikle SF; Posner SF; Jamieson DJ
AIDS; 2006 Sep; 20(14):1823-31. PubMed ID: 16954723
[TBL] [Abstract][Full Text] [Related]
38. Adherence to antiretroviral therapy in pregnancy.
Kingston MA; Letham CJ; McQuillan O
Int J STD AIDS; 2007 Nov; 18(11):787-9. PubMed ID: 18005515
[TBL] [Abstract][Full Text] [Related]
39. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.
Warszawski J; Tubiana R; Le Chenadec J; Blanche S; Teglas JP; Dollfus C; Faye A; Burgard M; Rouzioux C; Mandelbrot L;
AIDS; 2008 Jan; 22(2):289-99. PubMed ID: 18097232
[TBL] [Abstract][Full Text] [Related]
40. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
Palombi L; Marazzi MC; Voetberg A; Magid NA
AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
